Hepatitis B Immunoglobulin Immunoprophylaxis for Hepatitis B: High, Low, or No Dose?

被引：3
|
作者：
Gane, Ed [1 ]
机构：
[1] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland 1001, New Zealand
来源：
LIVER TRANSPLANTATION | 2010年 / 16卷
关键词：
LIVER-TRANSPLANT RECIPIENTS; RECEIVING LAMIVUDINE PROPHYLAXIS; ADEFOVIR DIPIVOXIL; VIRUS RECURRENCE; PASSIVE IMMUNOPROPHYLAXIS; COMBINATION; PREVENTION; PLUS; IMMUNIZATION; VACCINATION;
D O I：
10.1002/lt.22151
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Key Points 1. Transplantation for HBV-related HCC is increasing in the West, whilst HBV-relate liver failure is decreasing. 2. Combination lamivudine plus HBIG reduces the risk of HBV recurrence to less than 5%. 3. Low-dose IM HBIG ihas similar efficacy and better cost effectiveness than high-dose IV HBIG when combined with oral nucleos(t)ide therapy. 4. HBIG may be discontinued in low risk recipients (undetectable HBV DNA prior to transplant). 5. Combination of new potent antivirals without cross resistance may minimise the future need for post-operative HBIG. Liver Transpl 16:S36-S39, 2010. copy; 2009 AASLD. Copyright © 2009 American Association for the Study of Liver Diseases.
引用
收藏
页码：S36 / S39
页数：4
相关论文
共 50 条
  • [31] Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
    Choudhary, N. S.
    Saraf, N.
    Saigal, S.
    Mohanka, R.
    Rastogi, A.
    Goja, S.
    Menon, P. B.
    Soin, A. S.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (03) : 329 - 333
  • [32] PREVENTION OF NEONATAL HEPATITIS B WITH HIGH DOSE HEPATITIS B IMMUNE GLOBULIN (HBIG)
    DOSIK, H
    JHAVERI, R
    BLOOD, 1977, 50 (05) : 305 - 305
  • [33] The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence
    Vatansever, Sezgin
    Farajov, Rasim
    Yilmaz, Hoseyin Cahit
    Zeytunlu, Murat
    Kilic, Murat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 1019 - 1024
  • [34] Outcomes of hepatitis B patients transplanted without hepatitis B immunoglobulin
    Shah, Sheetal
    O'beirne, James
    Rosenberg, William
    Gathogo, Esther
    Westbrook, Rachel
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E480 - E480
  • [35] HEPATITIS-B IMMUNOGLOBULIN
    HYLAND, CA
    MEDICAL JOURNAL OF AUSTRALIA, 1981, 2 (08) : 386 - 386
  • [36] HEPATITIS-B IMMUNOGLOBULIN
    COSSART, Y
    GUST, I
    SCHIFF, P
    MEDICAL JOURNAL OF AUSTRALIA, 1982, 1 (10) : 407 - 408
  • [37] IMMUNOPROPHYLAXIS OF HEPATITIS B BY HUMAN ANTI-HB-AG IMMUNOGLOBULIN FOLLOWING ACCIDENTAL INOCULATION
    DAS, PC
    HOPKINS, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1974, 28 (01) : 147 - 148
  • [38] DURATION OF THE IMMUNOPROPHYLAXIS AFTER HEPATITIS-B VACCINE
    HERNANDEZ, JM
    PIQUERAS, J
    ESTEBAN, JI
    ESTEBAN, R
    MEDICINA CLINICA, 1985, 84 (17): : 714 - 715
  • [39] Combination lamivudine plus low dose intramuscular Hepatitis B immunoglobulin prevents recurrent Hepatitis B and may eradicate residual graft infection.
    Gane, EJ
    McCaughan, G
    Strasser, S
    Crawford, D
    Harley, H
    Jeffrey, G
    Schroeder, B
    Jackson, K
    Bowden, S
    Angus, P
    HEPATOLOGY, 2002, 36 (04) : 221A - 221A
  • [40] STRATEGIES FOR ACTIVE IMMUNOPROPHYLAXIS AGAINST HEPATITIS-B
    KRUGMAN, S
    BRANGIER, J
    TRICHOPOULOS, D
    DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION, 1983, 54 : 562 - 563
12345